{{Rsnum
|rsid=726601
|Gene=SORL1
|Chromosome=11
|position=121610698
|Orientation=plus
|GMAF=0.3682
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SORL1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 49.6 | 38.9 | 11.5
| HCB | 21.9 | 42.3 | 35.8
| JPT | 26.5 | 52.2 | 21.2
| YRI | 80.3 | 18.4 | 1.4
| ASW | 64.9 | 29.8 | 5.3
| CHB | 21.9 | 42.3 | 35.8
| CHD | 18.3 | 45.9 | 35.8
| GIH | 16.8 | 48.5 | 34.7
| LWK | 59.1 | 38.2 | 2.7
| MEX | 29.3 | 43.1 | 27.6
| MKK | 47.4 | 47.4 | 5.1
| TSI | 53.9 | 41.2 | 4.9
| HapMapRevision=28
}}[[rs726601]] is among several SNPs in the [[SORL1]] gene that show some association with increased (or decreased) risk for [[Alzheimer's disease]] in a study of 1,400 Caucasians.{{PMID|18090307|OA=1
}}

{{PMID Auto
|PMID=17903291
|Title=The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports.
|OA=1
}}

{{PMID Auto
|PMID=17903297
|Title=Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}